Balchem (BCPC) financial statements
Balchem reported revenue of $1.0B in fiscal 2025, up 7.2% a year over 9 years.
Net income was $155M and the operating margin 20.2%, against 16.4% in 2016.
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Balchem's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $553M | $595M | $644M | $644M | $704M | $799M | $942M | $922M | $954M | $1.0B |
| Cost of revenue | $372M | $406M | $439M | $432M | $480M | $556M | $662M | $620M | $617M | $667M |
| Gross profit | $181M | $189M | $204M | $211M | $224M | $243M | $280M | $302M | $336M | $371M |
| Research and development | $7M | $9M | $12M | $11M | $10M | $14M | $12M | $15M | $17M | $19M |
| Selling, general and admin | $83M | $83M | $86M | $97M | $102M | $102M | $123M | $128M | $137M | $143M |
| Operating income | $91M | $97M | $107M | $103M | $111M | $128M | $145M | $159M | $183M | $209M |
| Interest expense | $7M | $8M | — | — | — | — | — | — | — | — |
| Pre-tax income | $83M | $88M | $99M | $96M | $106M | $125M | $134M | $137M | $166M | $199M |
| Income tax | $27M | -$2M | $20M | $17M | $22M | $29M | $28M | $29M | $38M | $44M |
| Net income | $56M | $90M | $79M | $80M | $85M | $96M | $105M | $109M | $128M | $155M |
| EPS (diluted) | $1.75 | $2.79 | $2.42 | $2.45 | $2.60 | $2.94 | $3.25 | $3.35 | $3.93 | $4.75 |
| Diluted shares | 32M | 32M | 32M | 33M | 33M | 33M | 32M | 32M | 33M | 33M |
| Gross margin | 32.7% | 31.8% | 31.7% | 32.8% | 31.8% | 30.4% | 29.8% | 32.7% | 35.3% | 35.7% |
| Operating margin | 16.4% | 16.3% | 16.6% | 15.9% | 15.8% | 16.0% | 15.4% | 17.3% | 19.2% | 20.2% |
| Net margin | 10.1% | 15.1% | 12.2% | 12.4% | 12.0% | 12.0% | 11.2% | 11.8% | 13.5% | 14.9% |
Balance sheet
Fiscal years, from Balchem's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $39M | $40M | $54M | $66M | $85M | $103M | $67M | $64M | $50M | $75M |
| Receivables | $83M | $91M | $100M | $93M | $98M | $117M | $132M | $125M | $120M | $144M |
| Inventory | $57M | $61M | $67M | $84M | $71M | $91M | $120M | $110M | $131M | $131M |
| Total current assets | $188M | $199M | $226M | $255M | $267M | $322M | $336M | $314M | $314M | $366M |
| Property, plant and equipment | $166M | $190M | $191M | $217M | $228M | $238M | $271M | $276M | $282M | $307M |
| Goodwill | $440M | $441M | $448M | $524M | $529M | $524M | $770M | $779M | $780M | $816M |
| Total assets | $949M | $964M | $981M | $1.2B | $1.2B | $1.2B | $1.6B | $1.6B | $1.6B | $1.7B |
| Total current liabilities | $101M | $108M | $82M | $92M | $94M | $144M | $140M | $148M | $158M | $176M |
| Long-term debt | $226M | $0 | $156M | — | — | — | — | — | — | — |
| Total liabilities | $428M | $347M | $290M | $412M | $338M | $322M | $686M | $543M | $425M | $429M |
| Shareholders' equity | $521M | $617M | $692M | $744M | $828M | $877M | $938M | $1.1B | $1.1B | $1.3B |
| Net debt | $223M | -$5M | $102M | -$63M | -$85M | -$103M | -$67M | -$64M | -$50M | -$75M |
Cash flow
Fiscal years, from Balchem's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $108M | $111M | $119M | $124M | $150M | $161M | $139M | $184M | $182M | $217M |
| Capital spending | $23M | $28M | $19M | $26M | $32M | $36M | $49M | — | — | — |
| Free cash flow | $85M | $83M | $100M | $99M | $118M | $124M | $89M | — | — | — |
| Stock-based compensation | $7M | $6M | $6M | $8M | $8M | $11M | $13M | $16M | $17M | $18M |
| Dividends paid | $11M | $12M | $13M | $15M | $17M | $19M | $21M | $23M | $26M | $28M |
| Share buybacks (net) | -$2M | -$2M | -$1M | -$21M | -$13M | -$35M | -$35M | -$4M | -$6M | -$108M |
| Net borrowing | -$35M | -$43M | -$220M | — | — | — | — | — | — | — |
| Free cash flow margin | 15.3% | 14.0% | 15.5% | 15.3% | 16.8% | 15.6% | 9.5% | — | — | — |
| Dividends per share | $0.34 | $0.37 | $0.41 | $0.47 | $0.51 | $0.57 | $0.64 | $0.70 | $0.78 | $0.87 |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for BCPC.
Open BCPC in InvestinglyQuestions
What was Balchem's revenue in 2025?
$1.0B in fiscal 2025, from its 10-K filing.
From Balchem's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.